Author | Year | Country | Ethnicity | Gender | Study design | Diagnosis | Case | Control | HWE | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
VV | Vv | vv | VV | Vv | vv | ||||||||
Rs12722 | Â | Â | Â | Â | Â | Â | TT | TC | CC | TT | TC | CC | Â |
Alakhdar Y | 2021 | Spain | Caucasian | Both | Case–control | RCTEN | 11 | 31 | 7 | 36 | 47 | 5 | 0.04 |
Alakhdar Y | 2020 | Spain | Caucasian | Both | Case–control | ETEN | 12 | 20 | 4 | 35 | 58 | 8 | 0.02 |
Altinisik J | 2015 | Turkey | Caucasian | Both | Cohort | TE | 62 | 46 | 37 | 49 | 85 | 50 | 0.31 |
Brown KL | 2017 | UK | Caucasian | Both | Case–control | ATP | 22 | 48 | 29 | 34 | 64 | 27 | 0.76 |
Figueiredo EA | 2020 | Brazil | Mixed | Both | Case–control | RCT | 47 | 94 | 62 | 128 | 248 | 186 | 0.01 |
Haug KBF | 2018 | Norway | Caucasian | Both | Cohort | PTEN | 9 | 20 | 4 | 26 | 49 | 18 | 0.56 |
Kim H | 2015 | South Korea | Asian | Both | Case–control | ACLI, RUP | 0 | 15 | 20 | 0 | 8 | 31 | 0.48 |
Leźnicka K | 2021 | Poland | Caucasian | Both | Case–control | MI | 32 | 12 | 9 | 31 | 16 | 14 | 0.01 |
Longo UG | 2018 | Italy | Caucasian | Both | Case–control | RCT | 33 | 46 | 14 | 74 | 101 | 31 | 0.72 |
Lulińska-Kuklik E | 2018 | Poland | Caucasian | Male | Case–control | ACLI | 45 | 66 | 23 | 62 | 107 | 42 | 0.74 |
Miyamoto-Mikami E | 2019 | Japan | Asian | Both | Cohort | MI | 3 | 52 | 135 | 34 | 400 | 935 | 0.26 |
O'Connell K (I) | 2015 | South Africa | Caucasian | Both | Case–control | ACLI | 72 | 121 | 31 | 65 | 114 | 52 | 0.88 |
O'Connell K (II) | 2015 | Poland | Caucasian | Both | Case–control | ACLI | 32 | 44 | 15 | 38 | 75 | 30 | 0.54 |
Raleigh SM | 2009 | South Africa | Caucasian | Both | Case–control | TEN | 29 | 34 | 11 | 25 | 43 | 30 | 0.24 |
September AV (I) | 2009 | Australia | Caucasian | Both | Case–control | TEN | 17 | 58 | 10 | 74 | 84 | 50 | 0.01 |
September AV (II) | 2009 | South Africa | Caucasian | Both | Case–control | TEN | 34 | 47 | 12 | 39 | 55 | 37 | 0.07 |
Sivertsen EA | 2019 | Norway, Finland | Caucasian | Female | Cohort | ACLI | 48 | 55 | 15 | 256 | 351 | 124 | 0.85 |
Stepien-Slodkowska M | 2015 | Poland | Caucasian | Both | Case–control | ACLI | 48 | 66 | 24 | 53 | 91 | 39 | 0.99 |
Suijkerbuijk MAM (I) | 2019 | South Africa | Caucasian | Both | Case–control | ACLI | 20 | 48 | 25 | 13 | 47 | 36 | 0.71 |
Suijkerbuijk MAM (II) | 2019 | Sweden | Caucasian | Both | Case–control | ACLI | 23 | 36 | 18 | 38 | 47 | 24 | 0.20 |
Zhao D | 2020 | China | Asian | Both | Cross-sectional | ACLI | 8 | 37 | 56 | 6 | 36 | 68 | 0.67 |
Rs13946 | Â | Â | Â | Â | Â | Â | TT | TC | CC | TT | TC | CC | Â |
Leźnicka K | 2021 | Poland | Caucasian | Both | Case–control | MI | 26 | 20 | 7 | 28 | 26 | 7 | 0.80 |
Lulińska-Kuklik E | 2018 | Poland | Caucasian | Male | Case–control | ACLI | 75 | 49 | 10 | 94 | 102 | 15 | 0.07 |
Mokone GG | 2006 | South Africa | Caucasian | Both | Case–control | ATP | 65 | 41 | 5 | 75 | 40 | 14 | 0.03 |
September AV (I) | 2009 | Australia | Caucasian | Both | Case–control | TEN | 17 | 58 | 9 | 116 | 78 | 50 | 0.01 |
Sivertsen EA | 2019 | Norway, Finland | Caucasian | Female | Cohort | ACLI | 70 | 45 | 4 | 410 | 278 | 52 | 0.61 |
Stepien-Slodkowska M | 2015 | Poland | Caucasian | Both | Case–control | ACLI | 69 | 57 | 12 | 84 | 88 | 11 | 0.06 |
Zhao D | 2020 | China | Asian | Both | Cross-sectional | ACLI | 39 | 45 | 17 | 32 | 59 | 19 | 0.36 |
Rs11103544 | Â | Â | Â | Â | Â | Â | TT | TC | CC | TT | TC | CC | Â |
Figueiredo EA | 2020 | Brazil | Mixed | Both | Case–control | RCT | 147 | 52 | 12 | 182 | 96 | 14 | 0.77 |
September AV (I) | 2009 | Australia | Caucasian | Both | Case–control | TEN | 55 | 24 | 8 | 140 | 45 | 6 | 0.32 |
September AV (II) | 2009 | South Africa | Caucasian | Both | Case–control | TEN | 86 | 35 | 5 | 56 | 29 | 5 | 0.63 |
Rs71746744 | Â | Â | Â | Â | Â | Â | II | ID | DD | II | ID | DD | Â |
Abrahams Y (I) | 2013 | South Africa | Caucasian | Both | Case–control | TEN | 31 | 19 | 1 | 43 | 49 | 9 | 0.35 |
Abrahams Y (II) | 2013 | Australia | Caucasian | Both | Case–control | TEN | 25 | 12 | 3 | 45 | 37 | 15 | 0.13 |
Brown KL | 2017 | UK | Caucasian | Both | Case–control | ATP | 54 | 45 | 9 | 53 | 67 | 10 | 0.08 |
Rs3196378 | Â | Â | Â | Â | Â | Â | AA | AC | CC | AA | AC | CC | Â |
Abrahams Y (I) | 2013 | South Africa | Caucasian | Both | Case–control | TEN | 17 | 42 | 15 | 23 | 50 | 27 | 0.99 |
Abrahams Y (II) | 2013 | Australia | Caucasian | Both | Case–control | TEN | 7 | 46 | 10 | 28 | 105 | 42 | 0.01 |
Brown KL | 2017 | UK | Caucasian | Both | Case–control | ATP | 34 | 49 | 25 | 33 | 58 | 32 | 0.53 |
Figueiredo EA | 2020 | Brazil | Mixed | Both | Case–control | RCT | 53 | 105 | 53 | 115 | 260 | 189 | 0.15 |